| Line Item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|
| Profit or loss [abstract] | |||||||
| Revenues | |||||||
| Direct cost of revenues | |||||||
| Gross profit | |||||||
| Operating expenses | |||||||
| General and administrative | |||||||
| Research and development | |||||||
| Sales and marketing | |||||||
| Depreciation of property and equipment | |||||||
| Depreciation of right-of-use assets | |||||||
| Foreign exchange loss (gain) | |||||||
| Acquisition-related compensation | |||||||
| Amortization of intangible assets | |||||||
| Restructuring | |||||||
| Goodwill impairment | |||||||
| Total operating expenses | |||||||
| Operating loss | |||||||
| Net interest income | |||||||
| Loss before income taxes | |||||||
| Income tax expense (recovery) | |||||||
| Current | |||||||
| Deferred | |||||||
| Total income tax expense | |||||||
| Net loss |